Enfusion

Enfusion Gross Margin

Delisted

The Gross Margin of Enfusion (ENFN) as of Nov 7, 2026 is 67.82 %. In the previous year, Gross Margin was 66.97 % — a change of 1.27% (higher).

Gross Margin

67.82 %

YoY

1.27%

Last updated:

Gross Margin of Enfusion is 2024 67.82 % . Gross Margin of Enfusion was 2023 66.97 % . It decreases by 1.27% higher compared to the previous year.

Enfusion's gross margin stands at 67.8%, down from 74.7% several years earlier.

The Enfusion Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2019
71.27 USD
Jan 1, 2020
73.16 USD
Jan 1, 2021
71.49 USD
Jan 1, 2022
68.67 USD
Jan 1, 2023
66.97 USD
Jan 1, 2024
67.82 USD
The Enfusion Gross Margin history
YEARGross MarginYoY
67.82 %+1.27%
66.97 %-2.47%
68.67 %-3.94%
71.49 %-2.28%
73.16 %+2.65%
71.27 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

Gross Margin of Enfusion is 67.82 % in 2024.

Gross Margin of Enfusion changed from 66.97 % to 67.82 %, representing a 1.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Enfusion since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Enfusion with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Enfusion

All Key Metrics — Enfusion